ResMed | RMD - Loan Capital

Stock Price
204.15
Daily Change
2.27 1.12%
Monthly
-9.72%
Yearly
-19.42%
Q2 Forecast
197.82

ResMed reported $404.17M in Loan Capital for its fiscal quarter ending in March of 2026.





Loan Capital Change Date
Ansell USD 751.6M 113.1M Dec/2025
Artivion USD 215.35M 2.46M Mar/2026
AtriCure USD 61M 865K Mar/2026
Baxter International USD 8.62B 852M Mar/2026
Cochlear AUD 200M 6.5M Dec/2025
Cooper Companies USD 1.88B 578.5M Dec/2025
CSL USD 10.42B 273M Dec/2025
Dexcom USD 1.3B 54.4M Mar/2026
Edwards Lifesciences USD 600M 1.7M Mar/2026
Fisher Paykel Healthcare NZD 62.6M 4.3M Dec/2025
Globus Medical USD 436K 9K Dec/2025
Haemonetics USD 919.99M 406K Dec/2025
Idexx Laboratories USD 299.85M 74.99M Mar/2026
Inogen USD 0 0 Jun/2022
Insulet USD 929.5M 1.3M Mar/2026
Integra LifeSciences USD 1.83B 29.45M Mar/2026
Intuitive Surgical USD 0 0 Mar/2025
Masimo USD 445.7M 72.3M Mar/2026
Medtronic USD 27.88B 255M Dec/2025
Philips EUR 6.89B 43M Mar/2026
Ramsay Health Care AUD 11.2B 5.74B Dec/2025
ResMed USD 404.17M 245K Mar/2026
Sigma Healthcare AUD 1.88B 1.75B Dec/2025
Sonic Healthcare AUD 4.19B 333.39M Dec/2024
Steris USD 1.81B 85.6M Mar/2026
Teleflex USD 2.51B 27.18M Mar/2026
Thermo Fisher Scientific USD 40.07B 4.22B Mar/2026